Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Cancers-Is It the Way Forward?

Parth Desai; Neil D Gross; Kevin Contrera

doi:10.1001/jamaoto.2026.0081

Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Cancers-Is It the Way Forward?

Parth Desai
, Neil D Gross
, Kevin Contrera

MD Anderson Cancer Center
University of Pittsburgh

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Original language	English
Pages (from-to)	501-502
Number of pages	2
Journal	JAMA Otolaryngology - Head and Neck Surgery
Volume	152
Issue number	5
Early online date	Mar 12 2026
DOIs	https://doi.org/10.1001/jamaoto.2026.0081
State	Published - May 1 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1001/jamaoto.2026.0081

Cite this

@article{fa6c6681020a40c09d8ff2ce27ef3975,

title = "Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Cancers-Is It the Way Forward?",

author = "Parth Desai and Gross, \{Neil D\} and Kevin Contrera",

year = "2026",

month = may,

day = "1",

doi = "10.1001/jamaoto.2026.0081",

language = "English",

volume = "152",

pages = "501--502",

journal = "JAMA Otolaryngology - Head and Neck Surgery",

issn = "2168-6181",